|
BALTIMORE, MD—November 27, 2013—Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), is pleased to announce the availability of a new complimentary CME initiative in multiple sclerosis (MS) for neurologists.
Clinical Conversations in Neurology: Evaluating and Applying Contemporary Science in Multiple Sclerosis is a live, interactive educational activity that offers neurologists the opportunity to join their peers in a small-group discussion with nationally recognized MS experts about current questions and practice issues related to the use of disease-modifying therapies (DMTs).
The treatment of MS remains challenging for a variety of reasons, including a rapidly changing treatment landscape, a lack of definitive guidelines and algorithms to guide treatment decisions, a lack of validated tools for daily practice, and limitations of disease-modifying therapies (DMTs) and other available treatments.
“During these interactive CME teleconferences, we will outline strategies for using currently available agents appropriately, discuss the potential role of emerging agents, review approaches for monitoring treatment response, and explore methods of identifying and managing suboptimal response,” said Stephen Krieger, MD, Assistant Professor of Neurology of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai Medical Center. “Neurologists are invited to join my colleagues and me as we discuss challenges related to managing patients with MS and how to best utilize DMTs.”
The teleconferences are being held on the following dates:
FACULTY
 |
|
Benjamin M. Greenberg, MD, MHSc
Deputy Director, Multiple Sclerosis Program
Director, Transverse Myelitis and Neuromyelitis Optica Program
Director, Pediatric Demyelinating Disease Program
Cain Denius Scholar in Mobility Disorders
University of Texas Southwestern Medical Center
Dallas, TX
|
| |
|
|
 |
|
Stephen Krieger, MD
Assistant Professor of Neurology
Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Mount Sinai Medical Center
New York, NY
|
| |
|
|
 |
|
Robert T. Naismith, MD
Assistant Professor of Neurology
John L. Trotter Multiple Sclerosis Center
Washington University
St. Louis, MO
|
| |
|
|
 |
|
Annette Wundes, MD
Co-Director, UW Multiple Sclerosis Center
Assistant Professor in Neurology
Adjunct Assistant Professor in Rehabilitation Medicine
University of Washington
Seattle, WA
|
Registration is free. Interested neurologists can click here to schedule their teleconference date. For more information, visit www.Med-IQ.com/a717, call (toll-free) 866 858 7434, or e-mail info@med-iq.com.
What past Med-IQ Clinical Conversation participants are saying:
"It is like eavesdropping on how thought leaders approach patient care."
"The teleconference was a wonderful experience, and I would encourage all my fellows to do similar sorts of educational activities."
This activity is approved for AMA PRA Category 1 Credit™ and is supported by an educational grant from Genzyme, a Sanofi company.
|
|
About Med-IQ
Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.
Med-IQ, a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives, has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.
For more information, contact:
|
